Stem Cell Transplant for Immune Deficiency Syndrome

"The age requirements for this trial state that the youngest a participant can be is 8 years old, while the oldest a patient can be and still participate is 70."

"Yes, this trial is still open to recruitment and information on clinicaltrials.gov supports this claim. The listing was originally posted on July 24th, 2013 with the most recent update being made on October 31st, 2020."

"This clinical trial is looking for 144 participants, within the ages of 8 and 70 who have immunodeficiencies. It is required that patients also meet the following criteria:-Creatinine: Adult patients: less than or equal to 2.0 mg/dl and creatinine clearance greater than or equal to 30 ml/min; Pediatric patients (<18 years old): creatinine <1.5 mg/dL and a creatinine clearance , using the Schwartz Formula, > 30 mL/min/1.73m(2).-INCLUSION CRITERIA- Recipient,"

"Arm B's safety is rated a 2 because there is only evidence of its safety and no efficacy data."

"While Arm B is the most popular treatment for leukemia, it can also be used to effectively manage osteoporosis caused by glucocorticoid, lung cancers, and dermatitis, atopic."

"This is accurate. The website provides evidence that this study, which was originally posted on July 24th 2013 and last updated on October 31st 2020, is currently looking for 144 participants from 2 locations."

"At the moment, there are 1077 ongoing studies that focus on Arm B. Out of those 189 trials are currently in Phase 3. The majority of clinical trials for Arm B are located in Philadelphia, however, there 29790 different locations running studies for Arm B."